Bringing your virtual meetings to life!

2-Daiichi Sankyo-SAMSF-7-28-2022

 

Welcome to our virtual exhibit booth!

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.


Links


Contact

Heath St. Amant
Executive Oncology Territory Manager
hstamant@dsi.com
(228) 365-1820